Fitness6 months ago
Spur Therapeutics Presents Promising New Data from its GBA1 Parkinson’s Disease Research Program
Rationally engineered GCase85 enzyme reduces α-Synuclein accumulation, which plays a key role in the development and progression of Parkinson’s, in neuronal cells more effectively than wildtype...
